Psychiatric morbidity, illicit drug use and adherence to zidovudine (AZT) among injection drug users with HIV disease

American Journal of Drug and Alcohol Abuse

Volumn 22, Issue 4, 1996, Pages 475-487

  Ferrando, Stephen J ^a   Wall, Tamara L ^b   Batki, Steven L ^c   Sorensen, James L ^c  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ILLICIT DRUG; METHADONE; ZIDOVUDINE;

ADULT; ARTICLE; DRUG DEPENDENCE; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INTRAVENOUS DRUG ABUSE; LYMPHOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; MENTAL DISEASE; METHADONE TREATMENT; MORBIDITY; PATIENT COMPLIANCE;

EID: 0029827635     PISSN: 00952990     EISSN: None     Source Type: Journal    
DOI: 10.3109/00952999609001674     Document Type: Article

References (39)

1. Des Jarlais, D. C., Friedman, S. R., Sotheran, J. L., et al., Continuity and change within an HIV epidemic: Injecting drug users in New York City, 1984 through 1992, JAMA 271(2):121-127 (1994).
2. Firlik, A. D., and Schrieber K., AIDS prevention by needle exchange. N. Y. State J. Med. 92(10):426-430 (1992).
3. Sorensen, J. L., London, J., and Morales, E. S., Group counseling to prevent AIDS, in Preventing AIDS in Drug Users and Their Sexual Partners (J. S. Sorensen, L. A. Wermuth, D. R. Gibson, K. Choi, J. R. Guydish, and S. L. Batki, Eds.), Guilford Press, New York, 1991, pp. 99-115.
4. Sorensen, J. L., Batki, S. L., and Wilkinson, K., Methadone maintenance treatment for AIDS-affected addicts, J. Substance Abuse Treatment 6:87-94 (1989).
5. Selwyn, P. A., Feingold, A. F., Iezza, A , et al., Primary care for patients with human immunodeficiency virus (HIV) infection in a methadone maintenance treatment program, Ann. Intern. Med. 110:761-763 (1989).
6. Umbricht-Schneiter, A., Cinn, D. H., Pabst, K. M., and Bigelow, G. E., Providing medical care to methadone clinic patients: Referral vs. on site care, Am. J. Public Health 4(2) :207-210 (1994).
7. Batki, S. L., Ferrando, S. J., London, J., et al., Psychiatric disorders, drug use and HIV disease in HIV-infected intravenous drug users, Am. J. Addict. 5:249-258.
8. Fischl, M. A., Richman, D. D., Grieco, M. H., et al., The efficacy of azidothymidine (AZT) in the treatment of patients with AIDS and AIDS-related complex, N. Engl. J. Med. 317:185-191 (1987).
9. Fischl, M. A., Richman D. D., Hansen, N., et al., The safety and efficacy of zidovudine (AZT) in the treatment of subjects with mildly symptomatic human immunodeficiency virus type I (HIV) infection: A double-blind placebo-controlled trial, Ann. Intern. Med. 112:727-737 (1990).
10. Curtis, R., Friedman, S. R., Neaigus, A., et al., Implications of directly observed therapy in tuberculosis control measures among IDUs, Public Health Rept. 109(3) :329-327 (1994).
11. Nolan, C. M., Failure of therapy for tuberculosis in human immunodeficiency virus infection, Am. J. Med. Sci. 304(3):168-173 (1992).
12. Ball, S., and Sepkowitz, K., Tuberculosis and its management in patients with HIV disease, AIDS Reader 4:181-198 (1994).
13. Sackett, D. L., The magnitude of compliance and noncompliance, in Compliance with Therapeutic Regimens (D. L. Sackett and R. B. Haynes, Eds.), Johns Hopkins Univeristy Press, Baltimore, 1976, pp. 9-25.
14. Berg, J. S., Dischler, J., Wagner, D. J., et al., Medication compliance: A health care problem, Ann. Pharmacotherapy 27(suppl.):S1-24 (1993).
15. Adams, S. G., and Howe, T. T., Predicting medication compliance in a psychotic population, J. Nerv. Mem. Dis. 181(9):558-560 (1993).
16. Wolpe, P. R., Gorton, G., Scrota, R., and Sanford, B., Predicting compliance of dual diagnosis inpatients with aftercare treatment, Hosp. Commun. Psychiatry 44(1):45-49 (1993).
17. Fischl, M. A., Adherence in the safety and efficacy study of zidovudine in the treatment of subjects with mildly symptomatic HIV. Paper presented at the Conference of Adherence in AIDS Clinical Trials, April 1991, San Francisco, CA.
18. Samet, J. H., Libman, H., Steger, K. A., et al., Compliance with zidovudine therapy in patients infected with human immunodeficiency virus, type 1: A cross-sectional study in a municipal hospital clinic, Am. J. Med. 92:495-502 (1992).
19. Wall, T. L., Sorensen, J., London, J., et al., Adherence to zidovudine (AZT) in HIV-infected injection drug users, Problems of Drug Dependence 1992: Proceedings of the 54th Annual Scientific Meeting, The College on Problems of Drug Dependence, Inc. (L. S. Harris, Ed.), NIDA Research Monograph Series No. 132, U.S. Government Printing Office, Washington, D.C., 1993, p. 292.
20. Stein, M. D., Piette, J., Mor, V., et al., Differences in access to zidovudine (AZT) among symptomatic HIV-infected persons, J. Gen. Intern. Med. 6:35-40 (1991).
21. Richman, D. D., Fischl, M. A., Grieco, M. H., et al., The toxicity of azidothymidine (AZT) in the treatment of patients with AIDS and AIDS-related complex: A double-blind, placebo-controlled trial, N. Engl. J. Med. 317(45): 192-197 (1987).
22. Good, D. J., Reynolds, D. J., and De Miranda, P., Simultaneous quantification of zidovudine and its glucuronide in serum high-performance liquid chromated trial, N. Engl. J. Med. 317(45):1 (1987).
23. Collier, A., Henry, K., Japour, A., and van der Horst, C., Switching and combining anti-retroviral therapies, AIDS Clinical Care 5:33-37 (1993).
24. Centers for Disease Control, Update: Acquired immunodeficiency syndrome - United States 1981-1988, Morbid Mortal Weekly Rept. 36 (suppl.) :1-48 (1987).
25. Nathan, D. G., Hematologic diseases, in Cecil Textbook of Medicine, 19th ed. (J. B. Wyngaarden, L. H. Smith, and C J. Bennett, Eds.), W. B. Saunders, Philadelphia, 1992, p. 828.
26. Wu, A., Chanarin, I., and Levi, A. J., Macrocytosis of chronic alcoholism, Lancet 1:829-831 (1974).
27. Khantzian, E. J., and Treece, C., DSM III psychiatric diagnosis of narcotic addicts, Arch. Gen. Psychiatry 42:1067-1071 (1985).
28. Rounsaville, B. J., Weissman, M. M., Kleber, H., et al., Heterogeneity of psychiatric diagnosis in treated opiate addicts, Arch. Gen. Psychiatry 39:161-166 (1982).
29. Lipsitz, J. D., Williams, J. B., Rabkin, J. G., et al., Psychopathology in male and female intravenous drug users with and without HIV infection, Am. J. Psychiatry 151:1662-1668 (1994).
30. Perry, S., Jacobsberg, L. B., Fishman, B., et al., Psychiatric diagnosis before serological testing for the human immunodeficiency virus, Am. J. Psychiatry 147:89-93 (1990).
31. Williams, J. B. W., Rabkin, J. G., Remien, R. H., et al., Multidisciplinary baseline assessment of homosexual men with and without human immunodeficiency virus infection, Arch. Gen. Psychiatry 48:124-130 (1991).
32. Rothenberger, P. H., Bornstein, R. A., Nasrallah, H. A., et al., Psychopathology in human immunodeficiency virus infection: Lifetime and current assessment, Compr. Psychiatry 34:150-158 (1993).
33. Pantaleo, G., Graziosi, C., and Fauci, A., The immunopathogenesis of human immunodeficiency virus infection, N. Engl. J. Med. 328:327-335 (1993).
34. Selwyn, P. A., Alcabes, P, Hartel, D., et al., Clinical manifestations and predictors of disease progression in drug users with human immunodeficiency virus infection, N. Engl. J. Med. 327:1697-1703 (1992).
35. McArthur, J. C., Neurological and neuropathological manifestations of HIV infection, in Neuropsychology of HIV Infection (I. Grant and A. Martin, Eds.), Oxford University Press, New York, 1994, pp. 56-107.
36. Schmitt, F. A., Dickson, L. R., and Brouwers, P., Neuropsychological response to anti-retroviral therapy in HIV infection, in Neuropsychology of HIV Infection (I. Grant and A. Martin, Eds.), Oxford University Press, New York, 1994, pp. 276-294.
37. O'Dowd, M. A., and McKegney, P. F., Manic syndrome associated with zidovudine (letter), JAMA 260:3587-3588 (1988),
38. Crowe, S. M., McGrath, M. S., and Volberding, P., Anti-HIV therapy, AIDS Clin. Care 2:17-20 (1990).
39. Wall, T. L., Sorensen, J. L., Batki, S. L., et al., Adherence to zidovudine (AZT) among HIV-infected methadone patients: A pilot study of supervised therapy and dispensing compared to usual care, Drug Alcohol Depend. 37:261-269 (1995).